Literature DB >> 10357393

Gemfibrozil effectively lowers protease inhibitor-associated hypertriglyceridemia in HIV-1-positive patients.

R G Hewitt, M J Shelton, L D Esch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10357393     DOI： 10.1097/00002030-199905070-00023

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

Review 1.  Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

Authors:  G M Behrens; M Stoll; R E Schmidt
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

2.  Gemfibrozil concentrations are significantly decreased in the presence of lopinavir-ritonavir.

Authors:  Kristin H Busse; Colleen Hadigan; Cheryl Chairez; Raul M Alfaro; Elizabeth Formentini; Joseph A Kovacs; Scott R Penzak
Journal:  J Acquir Immune Defic Syndr       Date:  2009-10-01       Impact factor: 3.731

Review 3.  Evaluation and management of dyslipidemia in patients with HIV infection.

Authors:  Michael L Green
Journal:  J Gen Intern Med       Date:  2002-10       Impact factor: 5.128

4.  A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy.

Authors:  Alka Deshpande; Harsh Toshniwal; Shashank Joshi; Rajendrakumar H Jani
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.